Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Umesh A Badrising"'
Autor:
Karlien Mul, Marjolein Kriek, Baziel G.M. van Engelen, Saskia Lassche, Umesh A. Badrising, Nicol C. Voermans, Olivier W.H. van der Heijden, Nienke van der Stoep, Aimee D C Paulussen, Christine E. M. de Die-Smulders, Sanne C. C. Vincenten
Publikováno v:
Clinical Genetics, 101, 149-160
Clinical Genetics, 101, 2, pp. 149-160
Clinical Genetics, 101(2), 149-160. WILEY
Clinical Genetics, 101, 2, pp. 149-160
Clinical Genetics, 101(2), 149-160. WILEY
Contains fulltext : 248860.pdf (Publisher’s version ) (Open Access) Reproductive counseling in facioscapulohumeral muscular dystrophy (FSHD) can be challenging due to the complexity of its underlying genetic mechanisms and due to incomplete penetra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30298dec965d8f350bb49e2ddaed70ea
http://hdl.handle.net/2066/248860
http://hdl.handle.net/2066/248860
Autor:
Christa Walgaard, Bart C Jacobs, Hester F Lingsma, Ewout W Steyerberg, Bianca van den Berg, Alexandra Y Doets, Sonja E Leonhard, Christine Verboon, Ruth Huizinga, Judith Drenthen, Samuel Arends, Ilona Kleine Budde, Ruud P Kleyweg, Krista Kuitwaard, Marjon F G van der Meulen, Johnny P A Samijn, Frederique H Vermeij, Jan B M Kuks, Gert W van Dijk, Paul W Wirtz, Filip Eftimov, Anneke J van der Kooi, Marcel P J Garssen, Cees J Gijsbers, Maarten C de Rijk, Leo H Visser, Roderik J Blom, Wim H J P Linssen, Elly L van der Kooi, Jan J G M Verschuuren, Rinske van Koningsveld, Rita J G Dieks, H Job Gilhuis, Korné Jellema, Taco C van der Ree, Henriette M E Bienfait, Catharina G Faber, Harry Lovenich, Baziel G M van Engelen, Rutger J Groen, Ingemar S J Merkies, Bob W van Oosten, W Ludo van der Pol, Willem D M van der Meulen, Umesh A Badrising, Martijn Stevens, Albert-Jan J Breukelman, Casper P Zwetsloot, Maaike M van der Graaff, Marielle Wohlgemuth, Richard A C Hughes, David R Cornblath, Pieter A van Doorn, Bart C. Jacobs, Hester F. Lingsma, Ewout W. Steyerberg, Bianca Van den Berg, Alexandra Y. Doets, Sonja E. Leonhard, Ruud P. Kleyweg, Marjon F.G. Van der Meulen, Johnny P.A. Samijn, Frederique H. Vermeij, Jan B.M. Kuks, Gert W. Van Dijk, Paul W. Wirtz, Anneke J. Van der Kooi, Marcel P.J. Garssen, Cees J. Gijsbers, Maarten C. De Rijk, Leo H. Visser, Roderik J. Blom, Wim H.J.P. Linssen, Elly L. Van der Kooi, Jan J.G.M. Verschuuren, Rinske Van Koningsveld, Rita J.G. Dieks, H. Job Gilhuis, Taco C. Van der Ree, Henriette M.E. Bienfait, Karin G. Faber, Baziel G.M. Van Engelen, Rutger J. Groen, Ingemar S.J. Merkies, Bob W. Van Oosten, W. Ludo Van der Pol, Willem D.M. Van der Meulen, Umesh A. Badrising, Albert-Jan J. Breukelman, Casper P. Zwetsloot, Maaike M. Van der Graaff, Richard A.C. Hughes, David R. Cornblath, Pieter A. Van Doorn, R.B. Althingh van Geusau, C.J.M. Van Boheemen, I.M. Bronner, B. Feenstra, C. Fokke, T.A. Hoogendoorn, R. Van Houten, A. Hovestad, P.J.H.W. Jansen, E. Keuter, J. Krudde, F.H.H. Linn, J. Lion, S.M. Manschot, S.J. Mellema, D.S.M. Molenaar, D.J. Nieuwkamp, D.G. Oenema, J.C.H. Van Oostrom, N.P. Van Orshoven, R.J.O. Van der Ploeg, S. Polman, A. Ruitenberg, L. Ruts, A.J.G.M. Schyns-Soeterboek, R. Trip
Publikováno v:
The Lancet Neurology, 20(4), 275-283. Lancet Publishing Group
Walgaard, C, Jacobs, B C, Lingsma, H F, Steyerberg, E W, van den Berg, B, Doets, A Y, Leonhard, S E, Verboon, C, Huizinga, R, Drenthen, J, Arends, S, Budde, I K, Kleyweg, R P, Kuitwaard, K, van der Meulen, M F G, Samijn, J P A, Vermeij, F H, Kuks, J B M, van Dijk, G W, Wirtz, P W, Eftimov, F, van der Kooi, A J, Garssen, M P J, Gijsbers, C J, de Rijk, M C, Visser, L H, Blom, R J, Linssen, W H J P, van der Kooi, E L, Verschuuren, J J G M, van Koningsveld, R, Dieks, R J G, Gilhuis, H J, Jellema, K, van der Ree, T C, Bienfait, H M E, Faber, C G, Lovenich, H, van Engelen, B G M, Groen, R J, Merkies, I S J, van Oosten, B W, van der Pol, W L, van der Meulen, W D M, Badrising, U A, Stevens, M, Breukelman, A-J J, Zwetsloot, C P, van der Graaff, M M, Wohlgemuth, M, Hughes, R A C, Cornblath, D R, van Doorn, P A, Jacobs, B C, Lingsma, H F, Steyerberg, E W, Doets, A Y, Leonhard, S E, Kleine Budde, I, Kleyweg, R P, van der Meulen, M F G, Samijn, J P A, Vermeij, F H, Kuks, J B M, van Dijk, G W, Wirtz, P W, van der Kooi, A J, Garssen, M P J, Gijsbers, C J, de Rijk, M C, Visser, L H, Blom, R J, Linssen, W H J P, van der Kooi, E L, Verschuuren, J J G M, Dieks, R J G, Gilhuis, H J, van der Ree, T C, Bienfait, H M E, Faber, K G, van Engelen, B G M, Groen, R J, Merkies, I S J, van Oosten, B W, van der Pol, W L, van der Meulen, W D M, Badrising, U A, Breukelman, A-J J, Zwetsloot, C P, van der Graaff, M M, Hughes, R A C, Cornblath, D R, van Doorn, P A, Althingh van Geusau, R B, van Boheemen, C J M, Bronner, I M, Feenstra, B, Fokke, C, Hoogendoorn, T A, van Houten, R, Hovestad, A, Jansen, P J H W, Keuter, E, Krudde, J, Linn, F H H, Lion, J, Manschot, S M, Mellema, S J, Molenaar, D S M, Nieuwkamp, D J, Oenema, D G, van Oostrom, J C H, van Orshoven, N P, van der Ploeg, R J O, Polman, S, Ruitenberg, A, Ruts, L, Schyns-Soeterboek, A J G M, Trip, R & Dutch GBS Study Group 2021, ' Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial ', The Lancet Neurology, vol. 20, no. 4, pp. 275-283 . https://doi.org/10.1016/S1474-4422(20)30494-4
The Lancet Neurology, 20(4), 275-283. ELSEVIER SCIENCE INC
Lancet Neurology, 20(4), 275-283. ELSEVIER SCIENCE INC
Lancet Neurology, 20(4), 275-283. Elsevier Science
Lancet Neurology, 20, 275-283
Lancet neurology, 20(4), 275-283. Lancet Publishing Group
Lancet Neurology, 20, 4, pp. 275-283
Walgaard, C, Jacobs, B C, Lingsma, H F, Steyerberg, E W, van den Berg, B, Doets, A Y, Leonhard, S E, Verboon, C, Huizinga, R, Drenthen, J, Arends, S, Budde, I K, Kleyweg, R P, Kuitwaard, K, van der Meulen, M F G, Samijn, J P A, Vermeij, F H, Kuks, J B M, van Dijk, G W, Wirtz, P W, Eftimov, F, van der Kooi, A J, Garssen, M P J, Gijsbers, C J, de Rijk, M C, Visser, L H, Blom, R J, Linssen, W H J P, van der Kooi, E L, Verschuuren, J J G M, van Koningsveld, R, Dieks, R J G, Gilhuis, H J, Jellema, K, van der Ree, T C, Bienfait, H M E, Faber, C G, Lovenich, H, van Engelen, B G M, Groen, R J, Merkies, I S J, van Oosten, B W, van der Pol, W L, van der Meulen, W D M, Badrising, U A, Stevens, M, Breukelman, A-J J, Zwetsloot, C P, van der Graaff, M M, Wohlgemuth, M, Hughes, R A C, Cornblath, D R, van Doorn, P A, Jacobs, B C, Lingsma, H F, Steyerberg, E W, Doets, A Y, Leonhard, S E, Kleine Budde, I, Kleyweg, R P, van der Meulen, M F G, Samijn, J P A, Vermeij, F H, Kuks, J B M, van Dijk, G W, Wirtz, P W, van der Kooi, A J, Garssen, M P J, Gijsbers, C J, de Rijk, M C, Visser, L H, Blom, R J, Linssen, W H J P, van der Kooi, E L, Verschuuren, J J G M, Dieks, R J G, Gilhuis, H J, van der Ree, T C, Bienfait, H M E, Faber, K G, van Engelen, B G M, Groen, R J, Merkies, I S J, van Oosten, B W, van der Pol, W L, van der Meulen, W D M, Badrising, U A, Breukelman, A-J J, Zwetsloot, C P, van der Graaff, M M, Hughes, R A C, Cornblath, D R, van Doorn, P A, Althingh van Geusau, R B, van Boheemen, C J M, Bronner, I M, Feenstra, B, Fokke, C, Hoogendoorn, T A, van Houten, R, Hovestad, A, Jansen, P J H W, Keuter, E, Krudde, J, Linn, F H H, Lion, J, Manschot, S M, Mellema, S J, Molenaar, D S M, Nieuwkamp, D J, Oenema, D G, van Oostrom, J C H, van Orshoven, N P, van der Ploeg, R J O, Polman, S, Ruitenberg, A, Ruts, L, Schyns-Soeterboek, A J G M, Trip, R & Dutch GBS Study Group 2021, ' Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial ', The Lancet Neurology, vol. 20, no. 4, pp. 275-283 . https://doi.org/10.1016/S1474-4422(20)30494-4
The Lancet Neurology, 20(4), 275-283. ELSEVIER SCIENCE INC
Lancet Neurology, 20(4), 275-283. ELSEVIER SCIENCE INC
Lancet Neurology, 20(4), 275-283. Elsevier Science
Lancet Neurology, 20, 275-283
Lancet neurology, 20(4), 275-283. Lancet Publishing Group
Lancet Neurology, 20, 4, pp. 275-283
Summary Background Treatment with one standard dose (2 g/kg) of intravenous immunoglobulin is insufficient in a proportion of patients with severe Guillain-Barre syndrome. Worldwide, around 25% of patients severely affected with the syndrome are give
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fac234079bfe0a75e9f04cbd3f24fe28
https://research.vumc.nl/en/publications/ed0fb2cb-ebfd-4d51-a9f8-133541aa7cfa
https://research.vumc.nl/en/publications/ed0fb2cb-ebfd-4d51-a9f8-133541aa7cfa
Autor:
Michelle Mellion, Sander Brooks, Diego Cadavid, Shane Raines, Michelle Hage, Geert Jan Groeneveld, Cécile Berends, William G Tracewell, Adefowope Odueyungbo, Lorin A. Thompson, Lucienne Ronco, Michiel J van Esdonk, Lisa Pagan, Umesh A. Badrising, Emilie M J van Brummelen, Baziel G.M. van Engelen
Publikováno v:
British Journal of Clinical Pharmacology, 87(12), 4658-4669. WILEY
Aims Evaluate safety, tolerability, pharmacokinetics (PK) and target engagement (TE) of losmapimod in blood and muscle in facioscapulohumeral dystrophy (FSHD). Methods This study included Part A: 10 healthy volunteers randomized to single oral doses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc884dc6eac870563f6d4cc46fe9b44f
http://hdl.handle.net/1887/3248780
http://hdl.handle.net/1887/3248780
Autor:
Umesh A. Badrising, Jan De Bleecker, Anneke J. van der Kooi, Christiaan G J Saris, Marianne de Visser, Anke Rietveld, Johan Lim
Publikováno v:
Neurology: Neuroimmunology & Neuroinflammation, 6, 1
Neurology® neuroimmunology & neuroinflammation, 6(1):e513. Lippincott Williams and Wilkins
Neurology: Neuroimmunology & Neuroinflammation, 6
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION
Neurology, Neuroimmunology and Neuroinflammation, 6(1)
Neurology® Neuroimmunology & Neuroinflammation
Neurology® neuroimmunology & neuroinflammation, 6(1):e513. Lippincott Williams and Wilkins
Neurology: Neuroimmunology & Neuroinflammation, 6
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION
Neurology, Neuroimmunology and Neuroinflammation, 6(1)
Neurology® Neuroimmunology & Neuroinflammation
ObjectivesTo investigate the characteristics of different clinico-serologic subgroups of immune-mediated necrotizing myopathy (IMNM).MethodsWe retrospectively reviewed data from medical charts of 64 patients diagnosed with IMNM between 2012 and 2017
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00c96e613a3820ded67bbdb2ac58b5fb
https://hdl.handle.net/2066/201243
https://hdl.handle.net/2066/201243
Autor:
Hermien E. Kan, Umesh A. Badrising
Publikováno v:
Clinical Neuroradiology ISBN: 9783319614236
Clinical Neuroradiology
Clinical Neuroradiology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41376e48225a9d98727d21a8d5824f53
https://doi.org/10.1007/978-3-319-68536-6_75
https://doi.org/10.1007/978-3-319-68536-6_75
Publikováno v:
Neurology. 89(24)
Publikováno v:
Neurology, 89(24), E288-E289
A 52-year-old healthy woman presented with discomfort during running activities due to a protruding belly (figure 1, A and B). She was seen by a surgeon who performed a CT of the abdomen showing atrophy of the right abdominal muscles (figure 1C). Sub
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87696e53e7c923286531df6cdb7ad9df
http://hdl.handle.net/1887/88091
http://hdl.handle.net/1887/88091
Autor:
Jan J.G.M. Verschuuren, Erik H. Niks, Umesh A. Badrising, Pietro Spitali, Hanns Lochmüller, Monika Hiller, Teresinha Evangelista, Annemieke Aartsma-Rus, Roula Tsonaka
Publikováno v:
Journal of neuromuscular diseases. 4(4)
Background Inclusion body myositis is a late onset inflammatory myopathy lacking reliable serum biomarkers for diagnosis and for disease progression. Objective To identify diagnostic and predictive biomarkers, cytokine profiling is used to assess the
Autor:
Olivier Benveniste, C Brierley, Anke Rietveld, Stephen R Pye, Christiaan G J Saris, James B. Lilleker, Bryan Lecky, David Hilton-Jones, Pedro Machado, Neil McHugh, Sabrina Sacconi, Robert G. Cooper, Hector Chinoy, Megan K. Herbert, M. Parton, Ingrid E. Lundberg, James Miller, B.G.M. van Engelen, Kuberaka Mariampillai, Umesh A. Badrising, Janine A. Lamb, Michael G. Hanna, Karina Roxana Gheorghe, M T J Peeters, Mark E. Roberts, Ger J. M. Pruijn
Publikováno v:
Lilleker, J B, Rietveld, A, Pye, S R, Mariampillai, K, Benveniste, O, Peeters, M T J, Miller, J A L, Hanna, M G, Machado, P M, Parton, M J, Gheorghe, K R, Badrising, U A, Lundberg, I E, Sacconi, S, Herbert, M K, McHugh, N J, Lecky, B R F, Brierley, C, Hilton-Jones, D, Lamb, J A, Roberts, M E, Cooper, R G, Saris, C G J, Pruijn, G J M, Chinoy, H & Engelen, B G M V 2017, ' Cytosolic 5'-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis ', Annals of the rheumatic diseases, vol. 76, no. 5, pp. 862-868 . https://doi.org/10.1136/annrheumdis-2016-210282, https://doi.org/10.1136/annrheumdis-2016-210282
Annals of the Rheumatic Diseases, 76(5)
Annals of the Rheumatic Diseases
Lilleker, J B, Rietveld, A, Pye, S R, Mariampillai, K, Benveniste, O, Peeters, M T J, Miller, J A L, Hanna, M G, Machado, P M, Parton, M J, Gheorghe, K R, Badrising, U A, Lundberg, I E, Sacconi, S, Herbert, M K, McHugh, N J, Lecky, B R F, Brierley, C, Hilton-Jones, D, Lamb, J A, Roberts, M E, Cooper, R G, Saris, C G J, Pruijn, G J M, Chinoy, H, van Engelen, B G M 2017, ' Cytosolic 5'-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis ', Annals of the Rheumatic Diseases, vol. 76, no. 5 . https://doi.org/10.1136/annrheumdis-2016-210282
Annals of the Rheumatic Diseases, 76(5)
Annals of the Rheumatic Diseases
Lilleker, J B, Rietveld, A, Pye, S R, Mariampillai, K, Benveniste, O, Peeters, M T J, Miller, J A L, Hanna, M G, Machado, P M, Parton, M J, Gheorghe, K R, Badrising, U A, Lundberg, I E, Sacconi, S, Herbert, M K, McHugh, N J, Lecky, B R F, Brierley, C, Hilton-Jones, D, Lamb, J A, Roberts, M E, Cooper, R G, Saris, C G J, Pruijn, G J M, Chinoy, H, van Engelen, B G M 2017, ' Cytosolic 5'-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis ', Annals of the Rheumatic Diseases, vol. 76, no. 5 . https://doi.org/10.1136/annrheumdis-2016-210282
ObjectivesAutoantibodies directed against cytosolic 5′-nucleotidase 1A have been identified in many patients with inclusion body myositis. This retrospective study investigated the association between anticytosolic 5′-nucleotidase 1A antibody sta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dced853f227bacad031f9a610fe9bae
https://doi.org/10.1136/annrheumdis-2016-210282
https://doi.org/10.1136/annrheumdis-2016-210282
Autor:
Bas J. A. van Hoeve, Ingrid E. Lundberg, Annemarie van der Heijden, Wilbert C. Boelens, Helenius J. Schelhaas, Sander H. J. van Dooren, Marcel M. Verbeek, Judith Stammen-Vogelzangs, Umesh A. Badrising, Baziel G.M. van Engelen, Snjolaug Arnardottir, Helma Pluk, Karina Roxana Gheorghe, Ger J. M. Pruijn
Publikováno v:
Annals of Neurology. 73:397-407
OBJECTIVE: Sporadic inclusion body myositis (sIBM) is an inflammatory myopathy characterized by both degenerative and autoimmune features. In contrast to other inflammatory myopathies, myositis-specific autoantibodies had not been found in sIBM patie